Augment® Injectable Bone Graft

DEVICE2 trials

Sponsors

BioMimetic Therapeutics

Conditions

Ankle and Hindfoot ArthrodesisArthritisCongenital DeformityDegenerative Joint DiseaseOsteoarthritisRheumatoid Arthritis

Unknown Phase

Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions

CompletedNCT01305356

BioMimetic TherapeuticsArthritis, Congenital Deformity, Degenerative Joint Disease +2

Start: 2011-03-31End: 2014-04-30Updated: 2018-12-26

Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft

BioMimetic TherapeuticsAnkle and Hindfoot Arthrodesis

Start: 2019-08-31End: 2021-06-30Target: 94Updated: 2019-07-09